To include your compound in the COVID-19 Resource Center, submit it here.

Arena raises $352.8M after Phase II readout

Arena Pharmaceuticals Inc. (NASDAQ:ARNA) raised $352.8 million through the sale of 8.5 million

Read the full 133 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE